Concomitant Expression of Inhibitory Molecules for T cell Activation Predicts Poor Survival in Patients with Esophageal Squamous Cell Carcinoma

Chen, ZJ; Cao, KX; Zhang, JH; Liu, ZZ; Lu, LX; Qi, B; Shi, LJ; Huang, R; Zhao, S

Zhao, S (corresponding author), Zhengzhou Univ, Dept Thorac Surg, Affiliated Hosp 1, Zhengzhou, Peoples R China.; Huang, R (corresponding author), Xinxiang Med Univ, Lab Genet Regulators Immune Syst, Henan Collaborat Innovat Ctr Mol Diag & Lab Med, Sch Lab Med, Xinxiang, Henan, Peoples R China.

CURRENT CANCER DRUG TARGETS, 2021; 21 (3): 244

Abstract

Background: Esophageal squamous cell carcinoma (ESCC) is a major subtype of esophageal cancers. The five-year survival rate of ESCC is low, and molecu......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索